Table 1.
Baseline characteristics of allergic and non-allergic individuals.
| Clinical and demographic characteristics | All patients n = 1,172 (%) | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 503 (42.9) | |||
| Female | 669 (57.1) | |||
| Skin tests | ||||
| Grass positive | 638 (58.4) | |||
| Olive positive | 771 (70.5) | |||
| Profilin positive | 163 (15.1) | |||
| Polcalcin positive | 118 (12.1) | |||
| Allergy symptoms | ||||
| Rhinoconjunctivitis | ||||
| No | 81 (6.9) | |||
| Mild | 560 (47.8) | |||
| Moderate/severe | 531 (45.3) | |||
| Asthma | ||||
| No | 257 (21.9) | |||
| Mild | 564 (48.1) | |||
| Moderate-severe | 351 (29.9) | |||
| Immunotherapy | ||||
| No | 906 (77.7) | |||
| Grass and olive immunotherapy | 58 (5.0) | |||
| Only olive immunotherapy | 118 (10.1) | |||
| Only grass immunotherapy | 85 (7.3) | |||
| Mean | Median | SD* | IQR† | |
| Age | 26.4 | 24 | 13.6 | 16–37 |
| Total IgE (kU/L) | 443.6 | 193.5 | 673.7 | 74.2–495.3 |
| Lolium sIgE‡(kUA/L) | 21.4 | 3.5 | 52.8 | 0.2–17.4 |
| rPhl p 1,5 sIgE (kUA/L) | 20.5 | 4.7 | 43.2 | 0.5–19.4 |
| Olea sIgE (kUA/L) | 49.8 | 5.5 | 109.7 | 0.5–42.7 |
| Ole e 1 sIgE (kUA/L) | 34.4 | 4.6 | 81.4 | 0.6–26.1 |
| Ole e 7 sIgE (kUA/L) | 26.8 | 0.5 | 67.0 | 0.1–14.9 |
| Ole e 9 sIgE (kUA/L) | 14.7 | 0.0 | 43.7 | 0.0–3.4 |
SD*, standard deviation; IQR†, interquartile range; sIgE‡, specific Immunoglobulin E.